Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2015 (2015), Article ID 427163, 5 pages
http://dx.doi.org/10.1155/2015/427163
Case Report

Metastasis of Ciliary Body Melanoma to the Contralateral Eye: A Case Report and Review of Uveal Melanoma Literature

1Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
2Retina Consultants of Nashville, Nashville, TN, USA
3MD Anderson Cancer Center, Houston, TX, USA

Received 7 November 2014; Accepted 12 March 2015

Academic Editor: Jose I. Mayordomo

Copyright © 2015 Nouritza M. Torossian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. H. Abramson, A. C. Schefler, I. J. Dunkel et al., “Neoplasms of the eye,” in Cancer Medicine, R. Bast Jr., D. Kufe, and R. Pollick, Eds., pp. 1071–1083, BC Decker, London, UK, 7th edition, 2006. View at Google Scholar
  2. A. D. Singh, M. E. Turell, and A. K. Topham, “Uveal melanoma: trends in incidence, treatment, and survival,” Ophthalmology, vol. 118, no. 9, pp. 1881–1885, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. A. D. Singh, L. Bergman, and S. Seregard, “Uveal melanoma: epidemiologic aspects,” Ophthalmology Clinics of North America, vol. 18, no. 1, pp. 75–84, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. I. R. Yap-Veloso, R. B. Simmons, and R. J. Simmons, “Iris melanomas: diagnosis and management,” International Ophthalmology Clinics, vol. 37, no. 4, pp. 87–100, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Kujala, T. Mäkitie, and T. Kivelä, “Very long-term prognosis of patients with malignant uveal melanoma,” Investigative Ophthalmology & Visual Science, vol. 44, no. 11, pp. 4651–4659, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Y. Bedikian, S. S. Legha, G. Mavligit et al., “Treatment of uveal melanoma metastatic to the liver: a review of the MD Anderson Cancer Center experience and prognostic factors,” Cancer, vol. 76, pp. 1665–1670, 1995. View at Publisher · View at Google Scholar
  7. R. Kath, J. Hayungs, N. Bornfeld, W. Sauerwein, K. Hoffken, and S. Seeber, “Prognosis and treatment of disseminated uveal melanoma,” Cancer, vol. 72, no. 7, pp. 2219–2223, 1993. View at Publisher · View at Google Scholar · View at Scopus
  8. E. S. Gragoudas, K. M. Egan, J. M. Seddon et al., “Survival of patients with metastases from uveal melanoma,” Ophthalmology, vol. 98, no. 3, pp. 383–390, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Y. Bedikian, “Metastatic uveal melanoma therapy: current options,” International Ophthalmology Clinics, vol. 46, no. 1, pp. 151–166, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Shields, N. Perez, C. L. Shields, A. D. Singh, and R. C. Eagle Jr., “Orbital melanoma metastatic from contralateral choroid: management by complete surgical resection,” Ophthalmic Surgery and Lasers, vol. 33, no. 5, pp. 416–420, 2002. View at Google Scholar · View at Scopus
  11. C. Rosenberg and P. T. Finger, “Cutaneous malignant melanoma metastatic to the eye, lids, and orbit,” Survey of Ophthalmology, vol. 53, no. 3, pp. 187–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Shields and J. A. Shields, “Choroidal and retinal metastasis,” in Retinal and Choroidal Manifestations of Selected Systemic Diseases, J. F. Arévalo, Ed., vol. 14, pp. 267–282, Springer Science and Business Media, New York, NY, USA, 2013. View at Google Scholar
  13. J. Li, K. Resnick, and M. Tso, “Metastasis of malignant melanoma of the choroid and ciliary body to the contralateral choroid,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 231, no. 9, pp. 546–553, 1993. View at Publisher · View at Google Scholar · View at Scopus
  14. J. M. C. Mitjana, N. V. Grané, A. A. Civera, N. Sabater, L. A. Barquet, and M. J. R. Caso, “Clinical course of a presumed metastatic uveal melanoma to the contralateral choroid,” Seminars in Ophthalmology, 2013. View at Publisher · View at Google Scholar
  15. A. D. Singh, J. A. Shields, C. L. Shields, and T. Sato, “Choroidal melanoma metastatic to the contralateral choroid,” The American Journal of Ophthalmology, vol. 132, no. 6, pp. 941–943, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Khetan, S. Ambatipudi, and L. Gopal, “Presumed metastasis of choroidal melanoma to the contralateral choroid,” Retinal Cases and Brief Reports, vol. 4, no. 4, pp. 387–389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Shields, C. L. Shields, E. P. Shakin, and L. E. Kobetz, “Metastasis of choroidal melanoma to the contralateral choroid, orbit, and eyelid,” British Journal of Ophthalmology, vol. 72, no. 6, pp. 456–460, 1988. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Zografos, N. Ducrey, D. Beati et al., “Metastatic melanoma in the eye and orbit,” Ophthalmology, vol. 110, no. 11, pp. 2245–2256, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. Collaborative Ocular Melanoma Study Group, “Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma,” Archives of Ophthalmology, vol. 123, no. 12, pp. 1639–1643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. C. L. Shields, H. Demirci, M. A. Materin, B. P. Marr, A. Mashayekhi, and J. A. Shields, “Clinical factors in the identification of small choroidal melanoma,” Canadian Journal of Ophthalmology, vol. 39, no. 4, pp. 351–357, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. N. A. Kolandjian, C. Wei, S. P. Patel et al., “Delayed systemic recurrence of uveal melanoma,” American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 36, no. 5, pp. 443–449, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. E. C. Hsueh, R. Essner, L. J. Foshag, X. Ye, H.-J. Wang, and D. L. Morton, “Prolonged survival after complete resection of metastases from intraocular melanoma,” Cancer, vol. 100, no. 1, pp. 122–129, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Tschentscher, J. Hüsing, T. Hölter et al., “Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities,” Cancer Research, vol. 63, no. 10, pp. 2578–2584, 2003. View at Google Scholar · View at Scopus
  24. S. E. Coupland, S. L. Lake, M. Zeschnigk, and B. E. Damato, “Molecular pathology of uveal melanoma,” Eye, vol. 27, no. 2, pp. 230–242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. D. Onken, L. A. Worley, J. P. Ehlers, and J. W. Harbour, “Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death,” Cancer Research, vol. 64, no. 20, pp. 7205–7209, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. D. Onken, L. A. Worley, D. H. Char et al., “Collaborative ocular oncology group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma,” Ophthalmology, vol. 119, no. 8, pp. 1596–1603, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. M. D. Onken, L. A. Worley, M. D. Tuscan, and J. W. Harbour, “An accurate, clinically feasible multi-Gene expression assay for predicting metastasis in uveal melanoma,” Journal of Molecular Diagnostics, vol. 12, no. 4, pp. 461–468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. J. W. Harbour, M. D. Onken, E. D. O. Roberson et al., “Frequent mutation of BAP1 in metastasizing uveal melanomas,” Science, vol. 330, no. 6009, pp. 1410–1413, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. D. E. Jensen, M. Proctor, S. T. Marquis et al., “BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression,” Oncogene, vol. 16, no. 9, pp. 1097–1112, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. C. D. Van Raamsdonk, K. G. Griewank, M. B. Crosby et al., “Mutations in GNA11 in uveal melanoma,” The New England Journal of Medicine, vol. 363, no. 23, pp. 2191–2199, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. C. D. van Raamsdonk, V. Bezrookove, G. Green et al., “Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi,” Nature, vol. 457, no. 7229, pp. 599–602, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. A. Adjei, R. B. Cohen, W. Franklin et al., “Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers,” Journal of Clinical Oncology, vol. 26, no. 13, pp. 2139–2146, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Kirkwood, L. Bastholt, C. Robert et al., “Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma,” Clinical Cancer Research, vol. 18, no. 2, pp. 555–567, 2012. View at Publisher · View at Google Scholar · View at Scopus